Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

1. Chamorro-de-Vega, E.
2. Gimenez-Manzorro, A.
3. Rodriguez-Gonzalez, C.G.
4. Escudero-Vilaplana, V.
5. Collado Borrell, R.
6. Ibañez-Garcia, S.
7. Lallana Sainz, E.
8. Lobato Matilla, E.
9. Lorenzo-Pinto, A.
10. Manrique-Rodriguez, S.
11. Fernandez-Llamazares, C.M.
12. Marzal-Alfaro, M.
13. Ribed, A.
14. Romero Jimenez, R.M.
15. Sarobe Gonzalez, C.
16. Herranz, A.
17. Sanjurjo, M.